Screener
Gyre Therapeutics, Inc. GYRE Other Non-Current Assets
Other Non-Current Assets at other companies
Other financials
Where this comes from
Reported directly by Gyre Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.
The source filing: Gyre Therapeutics, Inc.’s 10-Q, filed August 7, 2026.
- Filed
- Aug 7, 2026, 5:00 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-340448
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Long-term prepayments | 302 | 112 |
| Deferred tax assets | 9,284 | 6,873 |
| Long-term certificates of deposit | 28,444 | 23,516 |
| Other assets, noncurrent | 7,344 | 7,624 |
| Total assets | $199,255 | $219,763 |
| Liabilities and stockholders' equity | ||
| Current liabilities: | ||
| Accounts payable | $1,236 | $1,335 |
ITEM 1. FINANCIAL STATEMENTS
FAQ
- What is Gyre Therapeutics, Inc.'s other non-current assets?
- Gyre Therapeutics, Inc. (GYRE) reported other non-current assets of $7.34M in Q2 2026.
- How has Gyre Therapeutics, Inc.'s other non-current assets changed year-over-year?
- Gyre Therapeutics, Inc.'s other non-current assets increased by 37.6% year-over-year, from $5.34M to $7.34M.
- What is the long-term trend for Gyre Therapeutics, Inc.'s other non-current assets?
- Over 5 years (2020 to 2025), Gyre Therapeutics, Inc.'s other non-current assets has grown at a 70.6% compound annual growth rate (CAGR), from $528K to $7.62M.
- What does other non-current assets mean?
- Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.
Ask your AI about Gyre Therapeutics, Inc.'s other non-current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude